English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [266]
News [1755]
Articles [54]
Editorials [3]
Conferences [47]
elearning [10]
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Molecule that combines three distinct technologies against most aggressive type of brain cancer is tested
Molecule that combines three distinct technologies against most aggressive type of brain cancer is t...
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone ma...
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Bridge therapy may benefit some children with high-risk neuroblastoma
Bridge therapy may benefit some children with high-risk neuroblastoma
ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas
ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric lo...
Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell lung cancer patients with brain metastases
Meta-analysis shows targeted radiation therapy may be as effective as standard care for small cell l...
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer
A nanoparticle and inhibitor trigger the immune system, outsmarting brain cancer
Epilepsy drug stops nervous system tumour growth in mice
Epilepsy drug stops nervous system tumour growth in mice
<12345...176>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307